☆ 4.7 Article

A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD

Nobuharu Tamaki et al.

Summary: This multicenter study evaluated the diagnostic accuracy of a two-step strategy combining Fibrosis-4 (FIB-4) and magnetic resonance elastography (MRE) for detecting advanced fibrosis (stage 3-4) in patients with nonalcoholic fatty liver disease (NAFLD). The results showed that the diagnostic accuracy of the two-step strategy was comparable to MRE alone, reducing excessive MRE and cost, and could be used as a screening method in a large population.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016

Pegah Golabi et al.

Summary: NAFLD subjects with fibrosis stage >= 2 have a high risk of mortality. The prevalence of moderate- or high-risk NAFLD is increasing over the years and is associated with increased all-cause, liver-related, and cardiovascular mortality.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/Non-Alcoholic Fatty Liver Disease (NAFLD) Registry

Zobair M. Younossi et al.

Summary: NAFLD patients from different countries experience a high comorbidity burden and impaired quality of life in real-world practices. Younger age, female gender, and nonhepatic comorbidities including fatigue are independent predictors of lower PRO scores. Patients whose fatigue scores improved over time experienced a substantial PRO improvement.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease

Sami Qadri et al.

Summary: This study investigated the impact of obesity on the performance of liver fibrosis biomarkers in NAFLD and found that ADAPT and FIB-4 are the best-performing biomarkers in obese patients, unaffected by body mass index.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis

Mazen Noureddin et al.

Summary: The study introduced a highly specific MRI-based score (MAST) to identify patients with Fibro-NASH, outperforming previous scores in non-invasively identifying patients at higher risk of liver disease progression.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Ferenc Emil Mozes et al.

Summary: Liver biopsy is still necessary for fibrosis staging in patients with non-alcoholic fatty liver disease. This study evaluated the diagnostic performance of liver stiffness measurement, FIB-4 Index, and NAFLD Fibrosis Score, and showed that sequential combinations of markers can reduce the need for liver biopsies.

GUT (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis

Nobuharu Tamaki et al.

Summary: The study compared the diagnostic accuracy of MEFIB and FAST for detecting significant fibrosis in NAFLD patients, finding that MEFIB had higher accuracy and supporting the use of a two-step strategy for detecting significant fibrosis in NAFLD.

HEPATOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Kenneth Cusi et al.

Summary: This article provides evidence-based recommendations for the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) for endocrinologists, primary care clinicians, and other stakeholders. The guideline includes 34 evidence-based clinical practice recommendations and contains relevant citations.

ENDOCRINE PRACTICE (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease

Kento Inada et al.

Summary: MEFIB is a useful method for detecting significant fibrosis in NAFLD patients and can be applied in different cohorts without changing the threshold of FIB-4, potentially serving as a two-step screening strategy.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Impact of non-invasive biomarkers on hepatology practice: Past, present and future

Quentin M. Anstee et al.

Summary: Over the past two decades, there have been significant advancements in the non-invasive diagnosis and risk stratification of chronic liver diseases (CLDs). Non-invasive approaches, such as quantifying biomarkers in serum samples or measuring liver stiffness using elastography techniques, have played a crucial role in clinical practice, including early cirrhosis identification, portal hypertension diagnosis, prognosis establishment in compensated cirrhosis, antiviral treatment guidance, and fibrosis and cirrhosis screening in primary care.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review

Michelle T. Long et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that can lead to serious complications and death. This article summarizes the epidemiological characteristics, prognosis, and mortality of lean individuals with NAFLD, and provides clinical practice recommendations.

GASTROENTEROLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants

Veeral Ajmera et al.

Summary: Liver stiffness assessed by magnetic resonance elastography (MRE) is associated with liver-related events, and the combination of MRE and Fibrosis-4 has excellent negative predictive value for hepatic decompensation.

GASTROENTEROLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease

Veeral Ajmera et al.

Summary: Liver stiffness assessed by magnetic resonance elastography (MRE) is associated with hepatic decompensation and death, and the combination of MRE with FIB-4, known as MEFIB, may have a high negative predictive value for liver-related events.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Predicting Liver-Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests

Amy L. Johnson et al.

Summary: Screening for advanced fibrosis in NAFLD patients from T2D clinics or primary care can help identify those at higher risk for liver-related complications. Prognostic value of baseline noninvasive fibrosis tests, such as NFS, FIB-4, ELF test, and LSMs, was shown in predicting liver outcomes and mortality. Patients with high-risk NFS, FIB-4 scores, or ELF test results were more likely to develop liver-related complications in the study.

HEPATOLOGY COMMUNICATIONS (2022)

添加到收藏夹

Letter Gastroenterology & Hepatology

Enhanced Liver Fibrosis Score Can Be Used to Predict Liver-Related Events in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis

Vijay S. Are et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

Zobair M. Younossi et al.

Summary: In patients with advanced NASH, baseline NIT scores and their changes over time are predictive factors for adverse clinical and PROs outcomes. Patients with higher NIT scores are more likely to experience disease progression and impaired PROs, while those with decreasing NIT scores may see improvements in PRO scores.

GASTROENTEROLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis

Jinho Jung et al.

Summary: The study demonstrated that the combination of MRE and FIB-4 showed high diagnostic accuracy in identifying patients with NAFLD who have stage 2 or higher fibrosis, making them suitable candidates for pharmacological therapy.

GUT (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019

Pegah Golabi et al.

Summary: NAFLD has emerged as a major cause of chronic liver disease globally, with Asia and MENA regions bearing a substantial burden of LC-NAFLD. Dietary risks, metabolic risks, and physical inactivity are positively correlated with DALYs related to NAFLD in these regions.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal et al.

Summary: In this study involving patients with nonalcoholic fatty liver disease, advanced fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death over a median of 4 years of follow-up. Advanced fibrosis was also related to an increased incidence of liver decompensation events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Rohit Loomba et al.

Summary: NAFLD and NASH are leading chronic liver diseases worldwide, causing progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. These diseases are associated with hepatic glucose and lipid metabolism, and are influenced by genetic, epigenetic, and environmental factors.

CELL (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

Emmanuel Anandraj Selvaraj et al.

Summary: Non-invasive tests measuring liver stiffness or using MRI have acceptable diagnostic accuracy for advanced fibrosis and cirrhosis. The potential clinical impact of these tests cannot be fully assessed due to lack of intention-to-diagnose analyses and validation of pre-specified thresholds.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

Fasiha Kanwal et al.

Summary: NAFLD is a common disease that affects a significant proportion of US adults. Management typically occurs in primary care or endocrine clinics, where accurate staging for fibrosis risk through screening is crucial, requiring consistent, timely, evidence-based, and easily testable management processes.

GASTROENTEROLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease

Anne-Marieke van Dijk et al.

Summary: In this study, FibroMeter versions were systematically reviewed for their performance in detecting different levels of fibrosis in patients with NAFLD. The findings indicated that FibroMeter VCTE had the highest diagnostic accuracy in detecting advanced fibrosis, followed by FibroMeter V2G and FibroMeter NAFLD, with no significant differences between the different versions. Head-to-head comparison studies are needed to further evaluate the performance of these tests.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Medicine, General & Internal

FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis

Yasaman Vali et al.

Summary: The meta-analysis showed that FibroTest(TM) performed well in detecting cirrhosis but had limited accuracy in detecting significant and advanced fibrosis in NAFLD patients. Further high-quality studies are needed to validate the test's reliability for detecting different fibrosis levels and to compare its performance in different settings.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease

Zobair M. Younossi et al.

Summary: The enhanced liver fibrosis (ELF) test performs well in identifying NAFLD patients at increased risk of advanced fibrosis, and when combined with the fib-4 score, it can be reliably used in clinical practice to assess the presence of advanced fibrosis among patients with NAFLD.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Determining a healthy reference range and factors potentially influencing PRO-C3 - A biomarker of liver fibrosis

Elisabeth Erhardtsen et al.

Summary: Through the study, the healthy reference range of PRO-C3 was established, and it was confirmed to reliably identify patients with clinically significant and advanced liver fibrosis in those with NAFLD/NASH.

JHEP REPORTS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Epidemiology of chronic liver diseases in the USA in the past three decades

Zobair M. Younossi et al.

GUT (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the US

Zobair M. Younossi et al.

DIABETES CARE (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD

James M. Paik et al.

HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population

Mehmet Sayiner et al.

HEPATOLOGY INTERNATIONAL (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

Yasaman Vali et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Review Cell Biology

Noninvasive Diagnosis of NAFLD and NASH

Valeria Annarita Piazzolla et al.

CELLS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices

Zobair M. Younossi et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis

Mazen Noureddin et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

Beth A. Davison et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study

Ma Ai Thanda Han et al.

LIVER INTERNATIONAL (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes

Zobair M. Younossi et al.

HEPATOLOGY COMMUNICATIONS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies

Yala K. Reddy et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States

Zobair M. Younossi et al.

HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis

Zobair M. Younossi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers

Uchenna Agbim et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

Arun J. Sanyal et al.

HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

Ankur Srivastava et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life

Zobair M. Younossi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA

Alexander L. Nguyen et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population

Tamoore Arshad et al.

HEPATOLOGY COMMUNICATIONS (2019)

添加到收藏夹

Article Medicine, General & Internal

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

David E. Kleiner et al.

JAMA NETWORK OPEN (2019)

添加到收藏夹

Article Medical Laboratory Technology

Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis

James Day et al.

JOURNAL OF APPLIED LABORATORY MEDICINE (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Zobair Younossi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

添加到收藏夹

Letter Medical Laboratory Technology

Enhanced Liver Fibrosis Score as a Predictor of Hepatocellular Carcinoma

Wai Mun Loo et al.

CLINICAL CHEMISTRY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

Eduardo Vilar-Gomez et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

Stuart McPherson et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Thomas Karlas et al.

JOURNAL OF HEPATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Hannes Hagstrom et al.

JOURNAL OF HEPATOLOGY (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting

Luca Miele et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

Katharine M. Irvine et al.

LIVER INTERNATIONAL (2016)

添加到收藏夹

Review Physiology

Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease

Joel T. Haas et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)

添加到收藏夹

Review Gastroenterology & Hepatology

MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice

Parambir S. Dulai et al.

JOURNAL OF HEPATOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

Siddharth Singh et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up

Mattias Ekstedt et al.

HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Utility of Magnetic Resonance Imaging Versus Histology for Quantifying Changes in Liver Fat in Nonalcoholic Fatty Liver Disease Trials

Mazen Noureddin et al.

HEPATOLOGY (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Pathologic Criteria for Nonalcoholic Steatohepatitis: Interprotocol Agreement and Ability to Predict Liver-Related Mortality

Zobair M. Younossi et al.

HEPATOLOGY (2011)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy

Scott B. Reeder et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

Julie Parkes et al.

GUT (2010)

添加到收藏夹

Article Medicine, General & Internal

Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures.

Reza Fazel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

Article Gastroenterology & Hepatology

FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest

Adays Vallet-Pichard et al.

HEPATOLOGY (2007)

添加到收藏夹

Article Gastroenterology & Hepatology

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

Paul Angulo et al.

HEPATOLOGY (2007)

添加到收藏夹

Article Gastroenterology & Hepatology

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Mattias Ekstedt et al.

HEPATOLOGY (2006)

添加到收藏夹

Article Acoustics

Transient elastography: A new noninvasive method for assessment of hepatic fibrosis

L Sandrin et al.

ULTRASOUND IN MEDICINE AND BIOLOGY (2003)

添加到收藏夹

Article Gastroenterology & Hepatology

The utility of radiological imaging in nonalcoholic fatty liver disease

S Saadeh et al.

GASTROENTEROLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.